Feb 15 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* REG-HERANTIS PHARMA PLC IS PLANNING A DIRECTED SHARE ISSUE
AND
PREPARES FOR A CONTEMPLATED SECONDARY LISTING ON THE FIRST NORTH
STOCKHOLM MARKETPLACE
* HERANTIS PHARMA - IS PREPARING FOR A CONTEMPLATED
SECONDARY
LISTING OF ITS SHARES ON FIRST NORTH STOCKHOLM MARKETPLACE,
WHICH IS EXPECTED TO TAKE PLACE IN 2019
* WILL CONSIDER A PUBLIC OFFERING OF A LIMITED NUMBER OF ITS
SHARES IN CONJUNCTION WITH SECONDARY LISTING
Source text for Eikon: ID:nGNE3NGgSJ
Further company coverage: HRTIS.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))